iRadimed Aktie
WKN DE: A118V4 / ISIN: US46266A1097
|
05.05.2025 13:56:13
|
Iradimed Corp Bottom Line Rises In Q1
(RTTNews) - Iradimed Corp (IRMD) revealed a profit for its first quarter that increased from last year
The company's bottom line came in at $4.7 million, or $0.37 per share. This compares with $4.1 million, or $0.32 per share, last year.
Excluding items, Iradimed Corp reported adjusted earnings of $5.3 million or $0.42 per share for the period.
The company's revenue for the period rose 10.8% to $19.5 million from $17.6 million last year.
Iradimed Corp earnings at a glance (GAAP) :
-Earnings: $4.7 Mln. vs. $4.1 Mln. last year. -EPS: $0.37 vs. $0.32 last year. -Revenue: $19.5 Mln vs. $17.6 Mln last year.
-Guidance: Next quarter EPS guidance: $0.41 to $0.44 Next quarter revenue guidance: $19.7-$19.9 Mln Full year EPS guidance: $1.71 to $1.81 Full year revenue guidance: $78-$82 Mln
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu iRadimed Corpmehr Nachrichten
|
04.05.25 |
Ausblick: iRadimed informiert über die jüngsten Quartalsergebnisse (finanzen.net) |
Analysen zu iRadimed Corpmehr Analysen
Aktien in diesem Artikel
| iRadimed Corp | 66,00 | 3,94% |
|